Sequanta Technologies Co., Ltd. and Mission Bio. are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio's products to customers in mainland China.
Single-cell genomics developer Mission Bio has made three new hires to build out its executive team, following a $30 million series B round late last year and a new deal to provide sequencing services to LabCorp and its Covance drug development business.